FLT3 and acute myeloid leukemia: Furthermore, midostaurin targeting Fms‐like tyrosine kinase (FLT3) mutation combined with chemotherapy has been recommended as frontline treatment in AML with FLT3 mutation AML by National Comprehensive Cancer Network (NCCN) guideline.2